Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
A mixture of: N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate; 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate; 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate
EC number: 403-410-1 | CAS number: 114565-65-0 C.I. DIRECT YELLOW 166; DIRECT YELLOW 166; GIALLO DIRETTO 166; JAUNE DIRECT 166; MONOAZO YELLOW MA 2822
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study conducted according to GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- (1983)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- A mixture of: N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate; 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate; 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate
- EC Number:
- 403-410-1
- EC Name:
- A mixture of: N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate; 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate; 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate
- Cas Number:
- 114565-65-0
- Molecular formula:
- C18 H16 N8 O3 S2 . x C7 H18 N2 . x C4 H11 N O2 . x C3 H9 N O
- IUPAC Name:
- (3-aminopropyl)diethylamine; 2-(methylamino)ethan-1-ol; 2-[(2-hydroxyethyl)amino]ethan-1-ol; 6-methyl-2-{4-[2-(2,4,6-triaminopyrimidin-5-yl)diazen-1-yl]phenyl}-1,3-benzothiazole-7-sulfonic acid
- Details on test material:
- - Name of test material (as cited in study report): FAT 11'184/B
- Physical state: powder, orange
- Analytical purity: No data mentioned in the report. However, in an Ames test report (CCR 124312, see IUCLID chapter 7.6.1) using the same batch of test substance the analytical purity was given as 89.6%.
- Lot/batch No.: Op. 1 BD 823/8
- Expiration date of the lot/batch: January, 1993
- Stability when pure: stable for 24 months
- Stability in vehicle: > 8 hours in H2O, ethanol, acetone, DMSO, and DMF
- Storage: at room temperature, light protected
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Zentralinstitut für Versuchstierzucht, Hannover, Germany
- Age at study initiation: about 15 weeks
- Weight at study initiation: approximately 30 g
- Assigned to test groups randomly: yes, the animals were distributed into the test groups at random and identified by cage number
- Housing: single, in Makrolon Type I cages with wire mesh top and granulated soft wood bedding
- Diet: pelleted standard diet (ALTROMIN), ad libitum
- Water: tap water, ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +/- 3
- Humidity (%): not regulated
- Air changes (per hr): no data given
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- On the day of the experiment, the test article was suspended in 4% Carboxymethyl cellulose (CMC). The vehicle was chosen due to its nontoxicity
for the animals. All animals received a single standard dose volume of 20 ml/kg bw orally. - Details on exposure:
- Pre-Experiment for Toxicity
For the purpose of dose selection, a preliminary study on acute toxicity was performed with the same strain and under identical conditions as in the mutagenicity assay. From the pre-experiment, the maximum tolerated dose level was determined as the dose that caused toxic reactions without having major effects on survival within 72 hours. In the present case, 4 animals (2 males, 2 females) received orally a single dose of 5000 mg/kg bw of the test article suspended in 4 % CMC. The volume administered was 20 ml/kg bw. All treated animals expressed toxic reactions consisting of reduction of spontaneous activity, eyelid closure and apathy. Thus, 5000 mg/kg bw was retained as dose level for the main test. - Duration of treatment / exposure:
- Treatment
Approximately 18 hours before treatment with the test article the animals received no food but water ad libitum. At the beginning of the treatment the animals were weighed and the individual volume to be administered was adjusted to the animal's body weight. The animals received the test article once. Twelve animals, six males and six females, were treated per dose group.
Sampling of the bone marrow was done 24, 48 and 72 hours after treatment.
The animals were sacrificed by cervical dislocation. The femora were removed, the epiphyses were cut off and the marrow was flushed out with 2.0 ml fetal calf serum, using a 5 ml syringe, into 1 ml fetal calf serum. The cell suspension was centrifuged at 1,000 rpm for 5 minutes and the supernatant was discarded. A small drop of the resuspended cell pellet was spread on a slide.
The smear was air-dried and then stained with May-Grünwald/Giemsa. Cover slips were mounted with EUKITT, at least one slide was made from each bone marrow sample. - Frequency of treatment:
- Single gavage
- Post exposure period:
- 24, 48 and 72 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
5000 mg/kg bw/day
Basis:
actual ingested
- No. of animals per sex per dose:
- Six males and six females were assigned to each test group.
The test comprised a series of 3 test groups (negative control, treated group, positive control) for bone marrow sampling after 24 hours post treatment, 2 test groups (negative control and treated) for bone marrow sampling after 48 hours post treatment, and further 2 test groups (negative control and treated) for bone marrow sampling after 72 hours. - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide (CPA) served for positive control substance.
The stability of CPA at room temperature is good; at 20°C only 1 % of CPA is hydrolysed per day in aqueous solution.
The substance was diluted in physiological saline at a dose level of 30 mg/kg bw/day; the solution was prepared on day of administration.
The animals were treated by single oral application (gavage), and the application volume was 10 ml/kg bw.
Examinations
- Tissues and cell types examined:
- Evaluation of the slides was performed using NIKON microscopes with 100x oil immersion objectives. 1,000 polychromatic erythrocytes (PCE) were analysed per animal for micronuclei. To describe a cytotoxic effect the ratio between polychromatic and normochromatic erythrocytes was determined in same sample and expressed in normochromatic erythrocytes per 1000 PCEs. The analysis was performed with coded slides. Five animals per sex and group were evaluated as described. The remaining animal of each test group was evaluated in case an animal had died in its test group spontaneously or due to gavage error.
- Evaluation criteria:
- A test article is classified as mutagenic if it induces either a statistically significant dose-related increase in the number of micronucleated polychromatic erythrocytes or a reproducible statistically significant positive response for at least one of the test points.
A test article producing neither a statistically significant dose-related increase in the number of micronucleated polychromatic erythrocytes nor a statistically significant and reproducible positive response at any one of the test points is considered non-mutagenic in this system.
This can be confirmed by means of the nonparametric Mann-Whitney test. However, both biological and statistical significance should be considered together. - Statistics:
- Statistical significance at the five per cent level (p < 0.05) was evaluated by means of the non-parametric Mann-Whitney test.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- After application of 5000 mg/kg bw of test article, the animals expressed same toxic symptoms as observed in the pre-experiment. One female died at preparation interval 48 hours.
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
Any other information on results incl. tables
SUMMARY OF THE RESULTS OF THE IN VIVO MICRONUCLEUS TEST WITH NMRI MICE (mean values) |
|||||||
Sampling time (hr) |
Test group |
Test dose (mg/kg bw) |
PCEs with Micronuclei (%) |
Genotoxicity |
PCE/NCE |
Cytotoxicity |
Toxic symptoms seen in the mice |
24 hours |
Solvent control |
0 |
0.12 |
no |
1000/458 |
no |
no |
Test article |
5000 |
0.03 |
no |
1000/536 |
no |
yes |
|
48 hours |
Solvent control |
0 |
0.1 |
|
1000/577 |
no |
no |
Test article |
5000 |
0.11 |
no |
1000/715 |
no |
yes and one case of death (♀) |
|
72 h |
Solvent control |
0 |
0.06 |
|
1000/533 |
no |
no |
Test article |
5000 |
0.09 |
no |
1000/569 |
no |
yes |
|
24 hours |
CPA |
30 |
1.34 |
yes |
1000/672 |
no |
no data |
PCE polychromatic erythrocytes; NCE normochromatic erythrocytes; CPA Cyclophosphamide (positive control) |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.